Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y
First Department of Surgery, Hamamatsu University School of Medicine, Japan.
J Surg Oncol. 1993 Feb;52(2):97-100. doi: 10.1002/jso.2930520208.
We investigated 230 systematically sampled fresh specimens from 12 early and 26 advanced gastric cancer patients by DNA flow cytometry for heterogeneity in DNA content. Fifty-eight percent of the 12 early gastric cancers were uniformly diploid and 42% were uniformly aneuploid. Fifty-four percent of advanced cancers were uniformly diploid in superficial layers and 42% were uniformly diploid in deep layers, whereas 46% were uniformly aneuploid in superficial layers, and 50% were uniformly aneuploid and 8% were heterogeneously aneuploid and diploid in deep layers. Both diploid and aneuploid samples were obtained from 15% for advanced cancers, but ploidy heterogeneity did not occur in early cancers. Heterogeneity for DNA index (more than one aneuploid DNA index) occurred in 46% of whole thickness of advanced cancers, in 19% of superficial layers of advanced cancers, and in 8% of early cancers. We concluded that DNA ploidy determination using superficial layer specimens may be reliable in early gastric cancer but must be interpreted with care in advanced cancer.
我们通过DNA流式细胞术对12例早期和26例进展期胃癌患者的230份系统采样的新鲜标本进行了研究,以检测DNA含量的异质性。12例早期胃癌中,58%为一致二倍体,42%为一致非整倍体。进展期癌中,54%的表层为一致二倍体,42%的深层为一致二倍体,而46%的表层为一致非整倍体,50%的深层为一致非整倍体,8%的深层为非整倍体与二倍体混合。进展期癌中15%的标本同时获得了二倍体和非整倍体样本,但早期癌未出现倍体异质性。DNA指数异质性(不止一个非整倍体DNA指数)在进展期癌全层的46%、进展期癌表层的19%以及早期癌的8%中出现。我们得出结论,使用表层标本进行DNA倍体测定在早期胃癌中可能可靠,但在进展期癌中必须谨慎解读。